Sodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we “gliflozin” patients with kidney stone disease?

ABSTRACT The prevalence of nephrolithiasis is increasing worldwide. Despite advances in understanding the pathogenesis of lithiasis, few studies have demonstrated that specific clinical interventions reduce the recurrence of nephrolithiasis. The aim of this review is to analyze the current data and...

Full description

Bibliographic Details

Published in:	Brazilian Journal of Nephrology
Main Authors:	Mauricio de Carvalho, Ita Pfeferman Heilberg
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Nefrologia 2024-02-01
Subjects:	Nephrolithiasis Kidney Calculi Sodium-Glucose Transporter 2 Inhibitors
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002024005005603&tlng=pt